These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35670970)

  • 61. Methylation of p16 CpG islands correlated with metastasis and aggressiveness in papillary thyroid carcinoma.
    Wang P; Pei R; Lu Z; Rao X; Liu B
    J Chin Med Assoc; 2013 Mar; 76(3):135-9. PubMed ID: 23497965
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
    Rosário PW; Calsolari MR
    Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of survivin expression and its prognostic value in papillary thyroid carcinoma.
    Selemetjev S; Dencic TI; Marecko I; Jankovic J; Paunovic I; Savin S; Cvejic D
    Pathol Res Pract; 2014 Jan; 210(1):30-4. PubMed ID: 24199968
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thyroid cancers with benign-looking sonographic features have different lymph node metastatic risk and histologic subtypes according to nodule size.
    Shin DY; Lee YK; Kim KJ; Park KH; Hwang S; Park SH; Kim EK; Kwon HJ; Lee EJ
    Endocr Pathol; 2014 Dec; 25(4):378-84. PubMed ID: 25182219
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevalence and aggressiveness of papillary thyroid carcinoma in surgically-treated graves' disease patients: a retrospective matched cohort study.
    You E; Mascarella MA; Al Jassim A; Forest VI; Hier MP; Tamilia M; Pusztaszeri M; Payne RJ
    J Otolaryngol Head Neck Surg; 2019 Aug; 48(1):40. PubMed ID: 31462328
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.
    Gąsior-Perczak D; Pałyga I; Szymonek M; Kowalik A; Walczyk A; Kopczyński J; Lizis-Kolus K; Trybek T; Mikina E; Szyska-Skrobot D; Gadawska-Juszczyk K; Hurej S; Szczodry A; Słuszniak A; Słuszniak J; Mężyk R; Góźdź S; Kowalska A
    PLoS One; 2018; 13(10):e0204668. PubMed ID: 30273371
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer.
    Niederer-Wüst SM; Jochum W; Förbs D; Brändle M; Bilz S; Clerici T; Oettli R; Müller J; Haile SR; Ess S; Stoeckli SJ; Broglie MA
    Surgery; 2015 Jan; 157(1):119-25. PubMed ID: 25482468
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Can Cervical Lymph Node Metastasis Increase the Risk of Distant Metastasis in Papillary Thyroid Carcinoma?
    Wang W; Ding Y; Jiang W; Li X
    Front Endocrinol (Lausanne); 2022; 13():917794. PubMed ID: 35813656
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epidermal growth factor receptor overexpression is a marker for adverse pathologic features in papillary thyroid carcinoma.
    Fisher KE; Jani JC; Fisher SB; Foulks C; Hill CE; Weber CJ; Cohen C; Sharma J
    J Surg Res; 2013 Nov; 185(1):217-24. PubMed ID: 23746767
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma.
    Kim HJ; Sohn SY; Jang HW; Kim SW; Chung JH
    World J Surg; 2013 Feb; 37(2):376-84. PubMed ID: 23135422
    [TBL] [Abstract][Full Text] [Related]  

  • 71. BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinoma.
    Givens DJ; Buchmann LO; Agarwal AM; Grimmer JF; Hunt JP
    Laryngoscope; 2014 Sep; 124(9):E389-93. PubMed ID: 24604709
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
    Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
    Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinicopathologic features and prognostic factors of tall cell variant of papillary thyroid carcinoma: comparison with classic variant of papillary thyroid carcinoma.
    Okuyucu K; Alagoz E; Arslan N; Emer O; Ince S; Deveci S; Ayan A; Taslipinar A; Gunalp B; Azal O
    Nucl Med Commun; 2015 Oct; 36(10):1021-5. PubMed ID: 26225942
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and Outcome.
    Wong KS; Dong F; Telatar M; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Afkhami M; Barletta JA
    Thyroid; 2021 Jun; 31(6):933-940. PubMed ID: 33143568
    [No Abstract]   [Full Text] [Related]  

  • 75. Invasiveness and Metastatic Aggressiveness in Small Differentiated Thyroid Cancers: Demography of Small Papillary Thyroid Carcinomas in the Swedish Population.
    Bayadsi H; Bergman M; Sund M; Hennings J
    World J Surg; 2020 Feb; 44(2):461-468. PubMed ID: 31834455
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics.
    Xu B; Tuttle RM; Sabra MM; Ganly I; Ghossein R
    Thyroid; 2017 May; 27(5):632-640. PubMed ID: 28049366
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Update to the College of American Pathologists reporting on thyroid carcinomas.
    Ghossein R
    Head Neck Pathol; 2009 Mar; 3(1):86-93. PubMed ID: 20596997
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients.
    Gunalp B; Okuyucu K; Ince S; Ayan A; Alagoz E
    Hell J Nucl Med; 2017; 20(2):122-127. PubMed ID: 28697188
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Influence of tumor extent on central lymph node metastasis in solitary papillary thyroid microcarcinomas: a retrospective study of 1092 patients.
    Yin X; Liu C; Guo Y; Li X; Shen N; Zhao X; Yu P; Wang S; Liu Z
    World J Surg Oncol; 2017 Jul; 15(1):133. PubMed ID: 28716127
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.